Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

Global aid funding cuts, led by the United States, are disrupting efforts to vaccinate children against deadly diseases ...

He is among four individuals wanted for allegedly using Thai nationals as nominee shareholders to conceal Chinese control of China Railway No 10 (Thailand) Co, a subsidiary of a Chinese state ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Article continues below Ozempic is ...

Meanwhile, US-listed shares of the Danish company Novo Nordisk, which markets both Ozempic and the higher-dose weight-loss variant Wegovy, slipped 3.9% amid concerns that a viable oral competitor ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Eli Lilly has been in a tight race with Ozempic and Wegovy-maker Novo Nordisk to enhance the potency of GLP-1 drugs and create a pill version in addition to the injectables that are already on the ...

Earlier this month, two sources told Reuters that Novo Nordisk A/S’ (NYSE:NVO) is trying to move up the launch of Wegovy in India to better compete with Lilly. Lakdawala also said Eli Lilly will ...